Jw Cayman Therapeutics Ltd.
Chinese cell‑therapy firm advancing multiple CAR‑T candidates—including relmacabtagene autoleucel for relapsed B‑cell lymphoma—and a broad pipeline targeting myeloma, solid tumours and auto‑immune disease, positioning it for growth in the expanding oncology market.
Headquarters: China (CHN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 292
- HQ: Shanghai
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.